In medical news:

As providers try to find non-addictive alternatives to opioids to treat pain, prescriptions for off-label use of gabapentin have been climbing, according to Cordant Health Solutions research. Perhaps best known for treating pain associated with shingles, gabapentin does not show affinity for the same types of receptor sites in the brain that are associated with drugs of abuse. But public health researchers are starting to sound an alarm, citing mounting evidence that gabapentin may not be as benign as once thought.

Read more here.

Leave a Comment

Your email address will not be published. Required fields are marked *